Fanconi anemia is a rare genetic disorder that is characterized by bone marrow failure and increased risk of developing leukemia and other cancers. Fanconi anemia drug market comprises drugs that are used for the treatment of bone marrow failure and blood related disorders associated with Fanconi anemia. Some of the major drugs available in the market are Lonafarnib, blood transfusions, growth factors, immunosuppressants, and a few others. Lonafarnib is one of the only approved drug for the ... Read more
